ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 387

$732K Total Retail Price of All Prescriptions

Rank: 64 out of 387

529 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 529 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 529 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 11,759 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 629 487 1 3
HYDROCODONE-ACETAMINOPHEN 610 473 S3 2 1
FUROSEMIDE 492 375 3 7
OMEPRAZOLE 455 335 4 4
SIMVASTATIN 400 305 5 5
TRAMADOL HCL 386 337 6 14
AMLODIPINE BESYLATE 383 360 7 6
METFORMIN HCL 362 250 8 8
LEVOTHYROXINE SODIUM 360 312 9 2
CITALOPRAM HBR 338 266 10 19
METOPROLOL TARTRATE 273 214 11 11
ZOLPIDEM TARTRATE 247 164 12 16
WARFARIN SODIUM 238 201 13 17
GABAPENTIN 224 169 14 10
POTASSIUM CHLORIDE 210 182 15 9
PRAVASTATIN SODIUM 205 178 16 15
ATORVASTATIN CALCIUM 204 189 17 13
HYDROCHLOROTHIAZIDE 195 169 18 12
CARVEDILOL 170 164 19 21
METOPROLOL SUCCINATE 160 159 20 18
ATENOLOL 149 143 21 20
DONEPEZIL HCL 142 142 22 27
ALLOPURINOL 138 100 23 28
MELOXICAM 132 107 24 22
IBUPROFEN 126 93 25 85
GLIMEPIRIDE 124 113 26 50
NEXIUM 123 110 27 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 112 28 30
SERTRALINE HCL 120 119 29 23
CLOPIDOGREL 110 102 30 25
DIOVAN 110 108 30 33
MIRTAZAPINE 108 96 32 64
LANTUS 105 97 33 51
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 92 34 90
TRAZODONE HCL 102 75 35 37
LOSARTAN POTASSIUM 89 84 36 24
CEPHALEXIN 84 78 37 135
FLUTICASONE PROPIONATE 82 63 38 29
AMLODIPINE BESYLATE-BENAZEPRIL 81 81 39 54
PLAVIX 78 68 40 39
AMITRIPTYLINE HCL 77 55 R 41 62
RISPERIDONE 75 66 42 70
SPIRIVA 74 60 43 61
ISOSORBIDE MONONITRATE ER 73 68 44 59
LYRICA 72 72 45 66
NAPROXEN 68 50 46 89
RANITIDINE HCL 67 54 47 45
CYMBALTA 67 31 47 44
DIGOXIN 67 62 47 40
NIFEDIPINE ER 66 56 50 136
CYCLOBENZAPRINE HCL 66 32 R 50 42
PROAIR HFA 66 49 50 47
PREMARIN 65 64 R 53 77
METOCLOPRAMIDE HCL 65 26 53 125
BENICAR 65 62 53 165
CRESTOR 65 64 53 34
CLONIDINE HCL 63 59 57 38
NAMENDA 62 62 58 35
OXYCODONE HCL-ACETAMINOPHEN 59 58 S2 59 98
MECLIZINE HCL 57 49 60 201
ESTRADIOL 56 37 R 61 105
PANTOPRAZOLE SODIUM 56 45 61 48
ESCITALOPRAM OXALATE 54 35 63 73
PREDNISONE 54 51 63 43
JANUVIA 53 41 65 60
POLYETHYLENE GLYCOL 3350 52 13 66 57
RAMIPRIL 51 51 67 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.